Chronic Obstructive Pulmonary Disease
Novartis
€ 196.75
FREE Delivery in Ireland
Description for Chronic Obstructive Pulmonary Disease
Hardcover. Chronic obstructive pulmonary disease (COPD), characterized by progressive chronic airflow obstruction, is the most common respiratory disorder of adults in the developed world and is the fourth main cause of death in the US. COPD has received little attention compared with other respiratory diseases such as asthma and lung cancer. Series: Novartis Foundation Symposia. Num Pages: 296 pages, Illustrations. BIC Classification: MFGC; MJL; PSD. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 232 x 157 x 19. Weight in Grams: 590.
Chronic obstructive pulmonary disease (COPD) is the most common respiratory disorder of adults in the developed world and is the fourth main cause of death in the USA. It is also associated with high morbidity, and poses an enormous burden of suffering and expense. Despite this, the disease has received little attention compared with other respiratory conditions such as asthma and lung cancer.
Current treatment can offer some marginal symptomatic relief but does not address the underlying disease process. Indeed, smoking cessation is the only intervention known to alter the rate of disease progression. There is clearly ... Read more
Chronic obstructive pulmonary disease (COPD) is the most common respiratory disorder of adults in the developed world and is the fourth main cause of death in the USA. It is also associated with high morbidity, and poses an enormous burden of suffering and expense. Despite this, the disease has received little attention compared with other respiratory conditions such as asthma and lung cancer.
Current treatment can offer some marginal symptomatic relief but does not address the underlying disease process. Indeed, smoking cessation is the only intervention known to alter the rate of disease progression. There is clearly ... Read more
Product Details
Format
Hardback
Publication date
2001
Publisher
John Wiley and Sons Ltd United Kingdom
Number of pages
296
Condition
New
Series
Novartis Foundation Symposia
Number of Pages
296
Place of Publication
New York, United States
ISBN
9780471494379
SKU
V9780471494379
Shipping Time
Usually ships in 7 to 11 working days
Ref
99-50
About Novartis
Derek J. Chadwick and Jamie A. Goode are editors for Chronic Obstructive Pulmonary Disease: Pathogenesis to Treatment and other scientific titles.
Reviews for Chronic Obstructive Pulmonary Disease
"The panel of speakers included some of the most distinguished scientists and physicians working in the field of COPD." (Biochemie, No. 83, 2001)